Dendritic cells in COVID-19 immunopathogenesis: insights for a possible role in determining disease outcome

RC Borges, MS Hohmann… - International Reviews of …, 2021 - Taylor & Francis
SARS-CoV-2 is the causative agent of the COVID-19 pandemic. This novel coronavirus
emerged in China, quickly spreading to more than 200 countries worldwide. Although most …

[HTML][HTML] Impaired cellular immunity to SARS-CoV-2 in severe COVID-19 patients

L Ni, ML Cheng, Y Feng, H Zhao, J Liu, F Ye… - Frontiers in …, 2021 - frontiersin.org
The high infection rate and rapid spread of severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) make it a world-wide pandemic. Individuals infected by the virus exhibited …

COVID-19: an immunopathological view

K Kadkhoda - MSphere, 2020 - Am Soc Microbiol
Since its emergence in December 2019, it took only a couple of months for an outbreak of
the novel coronavirus disease 2019 (COVID-19) to be declared a pandemic by the World …

The longitudinal immune response to coronavirus disease 2019: chasing the cytokine storm

AS Chau, AG Weber, NI Maria, S Narain… - Arthritis & …, 2021 - Wiley Online Library
The clinical progression of the severe acute respiratory syndrome coronavirus 2 infection,
coronavirus 2019 (COVID‐19), to critical illness is associated with an exaggerated immune …

[HTML][HTML] Immune response in severe and non-severe coronavirus disease 2019 (COVID-19) infection: a mechanistic landscape

K Mukund, P Nayak, C Ashokkumar, S Rao… - Frontiers in …, 2021 - frontiersin.org
The mechanisms underlying the immune remodeling and severity response in coronavirus
disease 2019 (COVID-19) are yet to be fully elucidated. Our comprehensive integrative …

[HTML][HTML] The first 12 months of COVID-19: a timeline of immunological insights

T Carvalho, F Krammer, A Iwasaki - Nature Reviews Immunology, 2021 - nature.com
Since the initial reports of a cluster of pneumonia cases of unidentified origin in Wuhan,
China, in December 2019, the novel coronavirus that causes this disease—severe acute …

[HTML][HTML] Single-cell landscape of immunological responses in patients with COVID-19

JY Zhang, XM Wang, X Xing, Z Xu, C Zhang… - Nature …, 2020 - nature.com
Abstract In coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection, the relationship between disease severity …

Immunological imprint of COVID‐19 on human peripheral blood leukocyte populations

B Kratzer, D Trapin, P Ettel, U Körmöczi, A Rottal… - Allergy, 2021 - Wiley Online Library
Background SARS‐CoV‐2 has triggered a pandemic that is now claiming many lives.
Several studies have investigated cellular immune responses in COVID‐19‐infected …

[HTML][HTML] Innate immune signaling and proteolytic pathways in the resolution or exacerbation of SARS-CoV-2 in Covid-19: key therapeutic targets?

JM Sallenave, L Guillot - Frontiers in immunology, 2020 - frontiersin.org
COVID-19 is caused by the Severe Acute Respiratory Syndrome (SARS) coronavirus (Cov)-
2, an enveloped virus with a positive-polarity, single-stranded RNA genome. The initial …

The immune system and COVID-19: Friend or foe?

F Yazdanpanah, MR Hamblin, N Rezaei - Life sciences, 2020 - Elsevier
Abstract Aim Coronavirus disease 2019 (COVID-19) is a novel highly contagious infection
caused by SARS-CoV-2, which has been became a global public health challenge. The …